Dihydrofluorescein diacetate
Names
[ CAS No. ]:
35340-49-9
[ Name ]:
Dihydrofluorescein diacetate
[Synonym ]:
MFCD00005056
Dihydrofluorescein diacetate
2-[3,6-Diacetoxy-9H-xanth-9-yl]benzoic acid
2-[3,6-Bis(acetyloxy)-9H-xanthen-9-yl]benzoic acid
D1845
2-(3,6-diacetoxy-xanthen-9-yl)-benzoic acid
2-(3,6-Diacetoxy-xanthen-9-yl)-benzoesaeure
Diacetyldihydrofluorescein
Biological Activity
[Description]:
[Related Catalog]:
[In Vitro]
[Cell Assay]
[References]
[Related Small Molecules]
Chemical & Physical Properties
[ Density]:
1.353g/cm3
[ Boiling Point ]:
554.3ºC at 760 mmHg
[ Melting Point ]:
213-215ºC(lit.)
[ Molecular Formula ]:
C24H18O7
[ Molecular Weight ]:
418.39600
[ Exact Mass ]:
418.10500
[ PSA ]:
99.13000
[ LogP ]:
4.52130
[ Index of Refraction ]:
1.626
[ Storage condition ]:
2-8℃
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Safety Phrases ]:
S22-S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2932999099
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2932999099
[ Summary ]:
2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
PLoS Negl. Trop. Dis. 9 , e0004145, (2015)
The high level of functional diversity and plasticity in monocytes/macrophages has been defined within in vitro systems as M1 (classically activated), M2 (alternatively activated) and deactivated macr...
Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells.MAbs 7(1) , 199-211, (2015)
Epratuzumab has demonstrated therapeutic activity in patients with non-Hodgkin lymphoma, acute lymphoblastic leukemia, systemic lupus erythematosus, and Sjögren's syndrome, but its mechanism of affect...
Po2 cycling protects diaphragm function during reoxygenation via ROS, Akt, ERK, and mitochondrial channels.Am. J. Physiol. Cell Physiol. 309 , C759-66, (2015)
Po2 cycling, often referred to as intermittent hypoxia, involves exposing tissues to brief cycles of low oxygen environments immediately followed by hyperoxic conditions. After experiencing long-term ...